March 14, 2025
Pineapple Inc. Provides Shareholder Update and 2025 Outlook
Company Expands into Cannabis Business Management and Functional Mushroom Markets to Drive Growth and Profitability LOS ANGELES, CA, March 13,…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
March 14, 2025
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
○ UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD)…
March 14, 2025
Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States
NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
March 14, 2025
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2024
MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for…
March 13, 2025
Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025
Breakthrough Adjuvant AB-801 Secures “Bioprocessing Excellence in Taiwan” HonorTAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE) — New-generation Contract Development and…
March 13, 2025
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering
IRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the…
March 13, 2025
Telix Adds Lead-212 Isotope Production Capability
MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company)…
March 12, 2025
CordenPharma & Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables & Oral Formulations
CordenPharma, a leading Contract Development & Manufacturing Organization (CDMO) specializing in the supply of peptide APIs and peptide-based therapeutic finished dosage drug products, is pleased to announce the signing of a strategic partnership with Viking Therapeutics, a clinical stage company focused on developing novel therapies for metabolic and endocrine disorders.
March 12, 2025
Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
RADNOR, Pa., March 11, 2025 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing…
March 12, 2025
Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem
$250,000 top award goes to Matteo Paz in America’s longest running and most distinguished science and math competitionTARRYTOWN, N.Y. and…